Overview - AUPH US

Aurinia Pharmaceuticals

AUPH.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

symbol	last	change	%chng	name	mcap	sector	wiki
AUPH				Aurinia Pharmaceuticals Inc	1.286B	Healthcare

	symbol	prev.close	range	chart	target	percent	period	months	due	rating
D	AUPH	8.86	0,-2.036,0.954,-0.337,-2.036	9.88,9.18,8.38,7.98,7.30,7.45,7.68,7.33,7.59,7.99,8.18,9.05,8.71,8.82	4.38-6.97	-35.96%	267,67,267	6.7	Oct 5-Jun 28	38.58%

Intraday chart for AUPH

Please reload the page if latest figures not showing

Key financials

The following extracted figures are selected by the AI as the most essential for predicting future price movements. The arrows show the how the AI thinks the figure affects the stock price (not the change in the figure)

. operatingIncome	-16M
. . netInterestIncome	3M
. incomeBeforeTax	-13M
. otherOperatingExpenses	71M
. netIncomeApplicableToCommonShares

. reconciledDepreciation	5M
. netWorkingCapital	353M
. netInvestedCapital	392M
. netDebt	47M
. totalCashFromOperatingActivities	-13M
. freeCashFlow. .	-13M

News for AUPH

headline news | recent news | latest news | market news

Chart AUPH

Similar stocks g.trial clinical

BeiGene Ltd	BGNE	US	Healthcare	24.8804	27267M	-
argenx NV ADR	ARGX	US	Healthcare	30.5813	20576M	-
Ascendis Pharma AS	ASND	US	Healthcare	30.3054	6621M	-
Apellis Pharmaceuticals Inc	APLS	US	Healthcare	55.6489	6056M	-
Crispr Therapeutics AG	CRSP	US	Healthcare	36.4419	4327M	-
Denali Therapeutics Inc	DNLI	US	Healthcare	65.694	4305M	-
Intellia Therapeutics Inc	NTLA	US	Healthcare	34.3129	3727M	-
Myovant Sciences Ltd	MYOV	US	Healthcare	29.3398	2614M	-
Xenon Pharmaceuticals Inc	XENE	US	Healthcare	21.9326	2451M	-
Syndax Pharmaceuticals Inc	SNDX	US	Healthcare	29.9689	1904M	-

Myshare aims to provide good clear honest and easy analysis of financial markets using a scientific, teaching and informative approach. We try hard but please read our disclaimer. Pages are provided by ourselves and our users. Register to edit pages and see the documentation

Global news | headline news | recent news | latest news | market news | topics | stock topics

News topics and stories from around the world and in the selected country

US News | headline news | recent news | latest news | market news | recent topics | stock topics

News from major news outlets like BBC, CNN and Reuters

Forecasts | Forecast buy | Forecast sell | Forecast up | Forecast down | Forecast sector

Long term stock predictions using AI reading the financial accounts of each company.

``` ``` ``` ```